[go: up one dir, main page]

GB2269747B - Aroyl-ureas as pharmaceuticals, particularly 5-ht3 antagonists - Google Patents

Aroyl-ureas as pharmaceuticals, particularly 5-ht3 antagonists

Info

Publication number
GB2269747B
GB2269747B GB9315168A GB9315168A GB2269747B GB 2269747 B GB2269747 B GB 2269747B GB 9315168 A GB9315168 A GB 9315168A GB 9315168 A GB9315168 A GB 9315168A GB 2269747 B GB2269747 B GB 2269747B
Authority
GB
United Kingdom
Prior art keywords
aroyl
ureas
antagonists
pharmaceuticals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9315168A
Other versions
GB9315168D0 (en
GB2269747A (en
Inventor
Terence James Ward
Gerald Bradley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
John Wyeth and Brother Ltd
Original Assignee
John Wyeth and Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929217629A external-priority patent/GB9217629D0/en
Application filed by John Wyeth and Brother Ltd filed Critical John Wyeth and Brother Ltd
Priority to GB9315168A priority Critical patent/GB2269747B/en
Publication of GB9315168D0 publication Critical patent/GB9315168D0/en
Publication of GB2269747A publication Critical patent/GB2269747A/en
Application granted granted Critical
Publication of GB2269747B publication Critical patent/GB2269747B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB9315168A 1992-08-19 1993-07-22 Aroyl-ureas as pharmaceuticals, particularly 5-ht3 antagonists Expired - Fee Related GB2269747B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9315168A GB2269747B (en) 1992-08-19 1993-07-22 Aroyl-ureas as pharmaceuticals, particularly 5-ht3 antagonists

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929217629A GB9217629D0 (en) 1992-08-19 1992-08-19 Aroylureas
GB9315168A GB2269747B (en) 1992-08-19 1993-07-22 Aroyl-ureas as pharmaceuticals, particularly 5-ht3 antagonists

Publications (3)

Publication Number Publication Date
GB9315168D0 GB9315168D0 (en) 1993-09-08
GB2269747A GB2269747A (en) 1994-02-23
GB2269747B true GB2269747B (en) 1996-06-05

Family

ID=26301458

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9315168A Expired - Fee Related GB2269747B (en) 1992-08-19 1993-07-22 Aroyl-ureas as pharmaceuticals, particularly 5-ht3 antagonists

Country Status (1)

Country Link
GB (1) GB2269747B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110288115A1 (en) * 2010-05-24 2011-11-24 Avmedis Llc Treatment of vagally-mediated spectrum disorders

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2213816A (en) * 1987-12-24 1989-08-23 Wyeth John & Brother Ltd Urea and carbamic acid derivitives of n-containing heterocylic compounds
GB2236528A (en) * 1989-10-07 1991-04-10 Wyeth John & Brother Ltd Aroyl-ureas

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2213816A (en) * 1987-12-24 1989-08-23 Wyeth John & Brother Ltd Urea and carbamic acid derivitives of n-containing heterocylic compounds
GB2236528A (en) * 1989-10-07 1991-04-10 Wyeth John & Brother Ltd Aroyl-ureas

Also Published As

Publication number Publication date
GB9315168D0 (en) 1993-09-08
GB2269747A (en) 1994-02-23

Similar Documents

Publication Publication Date Title
AU7947594A (en) Substituted amides as tachykinin antagonists
EP0557843A3 (en) Sulfonylbenzyl-substituted pyridones as pharmaceuticals
HU9603495D0 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, as pharmaceutical agents
ZA938647B (en) N,N-disubstituted arylcycloalkylamines
EP0666851A4 (en) Substituted phthalazinones as nerotensin antagonists.
AU2759892A (en) N-aryl-n1-azabicyclo-ureas as 5-ht3 antagonists
EP0662834A4 (en) Novel epoxide-containing compounds.
AU4668289A (en) Heteroazabenzobicyclic carboxamide 5-ht3, antagonists
GB9301660D0 (en) Pharmaceuticals
AP9400626A0 (en) Pharmaceuticals
GB9312348D0 (en) Pharmaceuticals
GB9321812D0 (en) Pharmaceuticals
GB2269747B (en) Aroyl-ureas as pharmaceuticals, particularly 5-ht3 antagonists
HU9402436D0 (en) 2,6-method-2h-quinolizin derivative as 5-ht3-receptor antagonist
GB9320316D0 (en) Pharmaceuticals
GR3033237T3 (en) Quinoline derivatives as leukoriene antagonists.
GB9303340D0 (en) Pharmaceuticals
AP9400684A0 (en) Pharmaceuticals
ZA936048B (en) Novel 3-oxadiazolyl-1,6-napthyridine derivatives
ZA945728B (en) 7-amino-1,1-dioxocefem l-valylamides
HU9401377D0 (en) 2,2-dialkyl-and 2,2-dialkil-3,4-dihydro-3-hydroxy-2h-1-benzo-pyrans, their use as pharmaceuticals
GB9326177D0 (en) Pharmaceuticals
GB9321394D0 (en) Pharmaceuticals
ZA932837B (en) Pharmaceuticals.
ZA934730B (en) Heterocyclic compounds as pharmaceuticals

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20010722